Articles
(CH), 114.9 (CH), 114.5 (Cq), 112.9 (Cq), 95.1 (Cq), 84.0 (Cq), 72.2 (CH2),
was cooled to 08C. DCC (15.2 g, 74 mmol, 1.03 equiv) was added
portionwise and the resulting suspension was allowed to warm to
RT for 3 h, filtered, and washed with CH2Cl2. The filtrate was
washed with a 0.5m aqueous solution of HCl (2ꢄ) and a saturated
aqueous solution of NaHCO3 (1ꢄ). The organic layer was dried over
Na2SO4, filtered, and concentrated. Column chromatography (SiO2,
95:5 cyclohexane/EtOAc) afforded 10 (10.82 g, 42.1 mmol, 58%) as
71.2 (CH2), 69.9 (CH2), 69.9 (CH2), 59.2 ppm (CH3); HRMS (ESI): m/z
+
+
calcd for C32H37N2O6
545.2646, 567.2466; found: 545.2609, 567.2443.
[M+H]+, C32H36N2NaO6
[M+Na]+:
N,N’-[({2,5-Bis[2-(2-methoxyethoxy)ethoxy]-1,4-phenylene}-
bis(ethyne-2,1-diyl))bis(4,1-phenylene)]bis(2-bromoacet-
amide) (7)
1
a yellow oil. H NMR (CDCl3, 300 MHz): d=7.47–7.24 (m, 5H), 3.80
(s, 2H), 1.84 ppm (s, 6H); 13C NMR (CDCl3, 100 MHz): d=165.1 (Cq),
144.6 (Cq), 128.1 (CH), 127.0 (CH), 123.9 (CH), 83.4 (Cq), 28.0 (CH3),
OPE-NH2 6 (798 mg, 1.465 mmol, 1.0 equiv) was dissolved in dry
CH2Cl2 (20 mL). The resulting solution was cooled to 08C, and trie-
thylamine (496 mL, 3.66 mmol, 2.5 equiv) was added, followed by
the dropwise addition of bromoacetyl bromide (319 mL, 3.66 mmol,
2.5 equiv) dissolved in dry CH2Cl2 (3 mL). The resulting mixture was
allowed to warm to RT for 3 h and washed with a saturated aque-
ous solution of NaHCO3 (1ꢄ) and a saturated aqueous solution of
NaCl (1ꢄ). The organic layer was dried over Na2SO4, filtered, and
concentrated. Compound 7 (459 mg, 0.584 mmol, 40%) was ob-
tained after column chromatography (SiO2, 40:60 to 20:80 cyclo-
hexane/EtOAc) as a pale yellow solid. 1H NMR (CDCl3, 300 MHz):
d=8.17 (s, 2H), 7.59–7.48 (m, 8H), 7.03 (s, 2H), 4.22 (t, J=4.8 Hz,
4H), 4.04 (s, 4H), 3.93 (t, J=4.8 Hz, 4H), 3.83–3.78 (m, 4H), 3.57–
3.52 (m, 4H), 3.37 ppm (s, 6H); 13C NMR (CDCl3, 75 MHz): d=163.4
(Cq), 153.7 (Cq), 137.1 (Cq), 132.6 (CH), 120.1 (Cq), 119.7 (CH), 117.6
(CH), 114.3 (Cq), 94.7 (Cq), 86.0 (Cq), 72.2 (CH2), 71.2 (CH2), 69.9 (CH2),
69.8 (CH2), 59.2 (CH3), 29.6 ppm (CH2); HRMS (ESI): m/z calcd for
+
27.0 ppm (CH2); HRMS (ESI): m/z calcd for C11H13BrNaO2 [M+Na]+:
278.9991; found: 278.9992.
Tris(2-phenylpropan-2-yl) 2,2’,2’’-(1,4,7,10-Tetraazacyclodo-
decane-1,4,7-triyl)triacetate (tri-Pp-DO3A 11)
Cyclen (2.41 g, 14 mmol, 1.0 equiv) was dissolved in MeCN
(150 mL). The resulting solution was cooled to 08C and NaHCO3
(3.53 g, 42 mmol, 3.0 equiv) was added. Compound 10 (10.8 g,
42 mmol, 3.0 equiv) dissolved in MeCN (40 mL) was added drop-
wise (ꢁ30 min). The resulting suspension was allowed to warm to
RT for 15 h and concentrated. CH2Cl2 was added and the mixture
was washed with H2O (1ꢄ) and a saturated aqueous solution of
NaCl (1ꢄ). The organic layer was dried over Na2SO4, filtered, and
concentrated. Column chromatography (SiO2, 98:2 to 95:5 CH2Cl2/
MeOH) afforded 11 (2.21 g, 3.15 mmol, 24%) as a light brown
foam. 1H NMR (CDCl3, 300 MHz): d=9.82 (s, 1H), 7.37–7.20 (m,
15H), 3.40–3.35 (m, 4H), 3.31 (s, 2H), 3.06–2.97 (m, 4H), 2.85–2.72
(m, 12H), 1.78 (s, 12H), 1.77 ppm (s, 6H); 13C NMR (CDCl3,
100 MHz): d=170.3 (Cq), 169.3 (Cq), 145.4 (Cq), 145.2 (Cq), 128.5
(CH), 127.5 (CH), 127.4 (CH), 124.4 (CH), 124.4 (CH), 82.9 (Cq), 82.8
(Cq), 57.9 (CH2), 52.1 (CH2), 51.8 (CH2), 49.7 (CH2), 49.3 (CH2), 47.3
(CH2), 28.8 (CH3), 28.8 ppm (CH3); HRMS (ESI): m/z calcd for
C36H38Br2N2NaO8 [M+Na]+: 809.0867; found: 809.0859.
+
General Procedure A: Synthesis of Protected Bis-DOTA Com-
pounds
Bromide 7 (1.0 equiv) and a DO3A derivative (tri-tBu-DO3A or tri-
Pp-DO3A 11) (2.5 equiv) were mixed in dry MeCN. K2CO3
(10.0 equiv) was added and the resulting mixture was heated at
608C for 15 h and concentrated. CH2Cl2 was added and the mixture
was washed with H2O (1ꢄ) and a saturated aqueous solution of
NaCl (1ꢄ). The organic layer was dried over Na2SO4, filtered, and
concentrated. Column chromatography afforded the correspond-
ing protected bis-DOTA-OPE compound as a yellow solid.
+
+
C41H57N4O6
[M+H]+, C41H56N4NaO6
[M+Na]+: 701.4273,
723.4092; found: 701.4315, 723.4096.
Pp-Protected Bis-DOTA-OPE (12)
By using general procedure A with 7 (71 mg, 0.09 mmol), 11
(161 mg, 0.23 mmol), and K2CO3 (124 mg, 0.9 mmol) in dry MeCN
(8 mL), Pp-protected bis-DOTA-OPE 12 (99 mg, 0.049 mmol, 54%)
was obtained after column chromatography (SiO2, 95:5 to 85:15
tBu-Protected Bis-DOTA-OPE (8)
1
CH2Cl2/MeOH). H NMR (CDCl3, 300 MHz): d=10.95 (s, 2H), 7.91 (d,
By using general procedure A with 7 (55 mg, 0.07 mmol), tri-tBu-
DO3A (100 mg, 0.174 mmol), and K2CO3 (96 mg, 0.7 mmol) in dry
MeCN (10 mL), tBu-protected bis-DOTA-OPE 8 (96 mg, 0.058 mmol,
83%) was obtained after column chromatography (SiO2, 90:10 to
80:20 CH2Cl2/MeOH). 1H NMR (CDCl3, 300 MHz): d=11.49 (s, 2H),
7.97 (d, J=8.5 Hz, 4H), 7.34 (d, J=8.5 Hz, 4H), 7.01 (s, 2H), 4.19 (t,
J=5.0 Hz, 4H), 3.91 (t, J=5.0 Hz, 4H), 3.83–3.78 (m, 4H), 3.75 (s,
4H), 3.55–3.50 (m, 4H), 3.34 (s, 6H), 3.30–1.85 (m, 44H), 1.48 (s,
18H), 1.43 ppm (s, 36H); 13C NMR (CDCl3, 75 MHz): d=172.34 (Cq),
171.6 (Cq), 153.6 (Cq), 140.1 (Cq), 131.8 (CH), 120.2 (CH), 117.6 (Cq),
114.5 (Cq), 95.9 (Cq), 84.7 (Cq), 82.4 (Cq), 82.2 (Cq), 72.2 (CH2), 71.2
(CH2), 69.9 (CH2), 69.9 (CH2), 59.1 (CH3), 57.0 (CH2), 55.9 (CH2), 55.8
(CH2), 51.3 (CH2), 28.2 (CH3), 28.1 ppm (CH3); HRMS (ESI): m/z calcd
J=8.4 Hz, 4H), 7.39 (d, J=8.4 Hz, 4H), 7.34–7.08 (m, 30H), 7.04 (s,
2H), 4.21 (t, J=4.9 Hz, 4H), 3.92 (t, J=4.9 Hz, 4H), 3.84–3.76 (m,
4H), 3.56–3.49 (m, 4H), 3.34 (s, 6H), 3.25–1.95 (m, 44H), 1.62 ppm
(s, 36H); 13C NMR (CDCl3, 100 MHz): d=171.6 (Cq), 171.0 (Cq), 153.6
(Cq), 145.7 (Cq), 140.1 (Cq), 131.8 (CH), 128.4 (CH), 127.2 (CH), 124.2
(CH), 124.1 (CH), 120.1 (CH), 117.6 (CH), 117.4 (Cq), 114.5 (Cq), 95.9
(Cq), 84.8 (Cq), 83.4 (Cq), 83.3 (Cq), 72.2 (CH2), 71.2 (CH2), 69.9 (CH2),
59.1 (CH3), 56.6 (CH2), 55.8 (CH2), 55.7 (CH2), 54–50.5 (CH2, broad
cluster), 50–47.5 (CH2, broad cluster), 33–24 ppm (CH3, broad clus-
ter); HRMS (ESI): m/z calcd for C118H148N10Na2O202+/2 [M+2Na]2+
,
C118H149N10NaO202+/2 [M+H+Na]2+: 1035.5328, 1025.0435; found:
1035.5329, 1025.0453.
for C88H136N10NaO20 [M+Na]+: 1675.9825; found: 1675.9832.
+
Bis-DOTA-OPE (13)
2-Phenylpropan-2-yl 2-Bromoacetate (10)
Pp-protected bis-DOTA-OPE 12 was dissolved in a mixture of TFA/
TIS/CH2Cl2 (2:2:96, 10 mgmLꢀ1). The resulting solution was stirred
at RT for 4 h and concentrated. MeOH was added and the product
was precipitated by slow addition of Et2O, filtered, and dried. The
Bromoacetic acid (10.0 g, 72 mmol, 1.0 equiv) and
109 mmol, 1.5 equiv) were dissolved in CH2Cl2 (100 mL). DMAP
(880 mg, 7.2 mmol, 0.1 equiv) was added and the resulting mixture
9 (14.8 g,
ChemPhysChem 2016, 17, 1 – 14
9
ꢂ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
These are not the final page numbers! ÞÞ